P2RY12

Chr 3AR

purinergic receptor P2Y12

Also known as: ADPG-R, BDPLT8, HORK3, P2T(AC), P2Y(12)R, P2Y(AC), P2Y(ADP), P2Y(cyc)

The product of this gene belongs to the family of G-protein coupled receptors. This family has several receptor subtypes with different pharmacological selectivity, which overlaps in some cases, for various adenosine and uridine nucleotides. This receptor is involved in platelet aggregation, and is a potential target for the treatment of thromboembolisms and other clotting disorders. Mutations in this gene are implicated in bleeding disorder, platelet type 8 (BDPLT8). Alternative splicing results in multiple transcript variants of this gene. [provided by RefSeq, Jul 2013]

OMIMResearchGenerating clinical summary…
MultiplemechanismARLOEUF 1.411 OMIM phenotype
Clinical SummaryP2RY12
🧬
Gene-Disease Validity (ClinGen)
platelet-type bleeding disorder 8 · ARDefinitive

Definitive — sufficient evidence for diagnostic panels

2 total gene-disease associations curated

Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
21 unique Pathogenic / Likely Pathogenic· 233 VUS of 348 total submissions
💊
Clinical Trials
1 active or recruiting trial — potential therapeutic options may be available

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
1.41LOEUF
pLI 0.002
Z-score 0.82
OE 0.68 (0.351.41)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint?
0.86Z-score
OE missense 0.82 (0.720.94)
152 obs / 185.0 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.68 (0.351.41)
00.351.4
Missense OE?0.82 (0.720.94)
00.61.4
Synonymous OE?0.97
01.21.6
LoF obs/exp: 5 / 7.4Missense obs/exp: 152 / 185.0Syn Z: 0.18

This gene — mechanism propensity

DN
0.78top 25%
GOF
0.80top 10%
LOF
0.2288th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

348 submitted variants in ClinVar

Classification Summary

Pathogenic6
Likely Pathogenic15
VUS233
Likely Benign64
Benign12
Conflicting7
6
Pathogenic
15
Likely Pathogenic
233
VUS
64
Likely Benign
12
Benign
7
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
5
1
0
0
6
Likely Pathogenic
12
3
0
0
15
VUS
5
223
5
0
233
Likely Benign
0
16
5
43
64
Benign
0
2
4
6
12
Conflicting
7
Total222451449337

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

19 pathogenic / likely-pathogenic (of 29) ClinVar copy-number / structural variants overlap P2RY12 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

P2RY12 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.